Fluid resuscitation with hemoglobin-vesicle solution does not increase hypoxia or inflammatory responses in moderate hemorrhagic shock

Biomedical Research

Volumn 27, Issue 6, 2007, Pages 283-288

  Goto, Yoshitugu ^a   Terajima, Katsuyuki ^a   Tsueshita, Takaya ^a   Miyashita, Masao ^a   Horinouchi, Hirohisa ^b   Sakai, Hiromi ^c   Tsuchida, Eishun ^c   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; MESSENGER RNA; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE MODEL; FLUID RESUSCITATION; HEART; HEMORRHAGIC SHOCK; HYPOXIA; INFLAMMATION; KIDNEY; LACTATE BLOOD LEVEL; LIVER; LUNG; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPLEEN; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; BLOOD PRESSURE; BLOOD SUBSTITUTES; HEMOGLOBINS; INFLAMMATION; ISOTONIC SOLUTIONS; LACTIC ACID; MALE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; RNA, MESSENGER; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 33846312141     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.27.283     Document Type: Article

References (32)

1. Biarent D, Hubloue I, Bejjani G, Melot C, Jespers P, Naeije R and Leeman M (2006) Role of endothelins and nitric oxide in the pulmonary circulation of perinatal lambs during hyperoxia and hypoxia. Pediatr Res 59, 131-136.
2. Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ and Silliman CC (2001) Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity-abrogation by poststorage washing but not prestorage leukoreduction. J Trauma 50, 426-431.
3. Biffl WL, Moore EE, Zallen G, Johnson JL, Gabriel J, Offner PJ and Silliman CC (1999) Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery 126, 198-202.
4. Botha AJ, Moore FA, Moore EE, Kim FJ, Banerjee A and Peterson VM (1995) Postinjury neutrophil priming and activation: an early vulnerable window. Surgery 118, 358-365.
5. Boura C, Caron A, Longrois D, Mertes PM, Labrude P and Menu P (2003) Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock 19, 176-182.
6. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15, 532-534, 536-537.
7. Dalen T, Bengtsson A, Brorsson B and Engstrom KG (2003) Inflammatory mediators in autotransfusion drain blood after knee arthroplasty, with and without leucocyte reduction. Vox Sang 85, 31-39.
8. Dong F, Hall CH, Golech SA, Philbin NB, Rice JP, Gurney J, Arnaud FG, Hammett M, Ma X, Flournoy WS, Hong J, Kaplan LJ, Pearce LB, McGwin G, Ahlers S, McCarron R and Freilich D (2006) Immune effects of resuscitation with HBOC-201, a hemoglobin-based oxygen carrier, in swine with moderately severe hemorrhagic shock from controlled hemorrhage. Shock 25, 50-55.
9. Eckardt KU and Kurtz A (2005) Regulation of erythropoietin production. Eur J Clin Invest 35, 13-19.
10. Gulati A, Sen AP, Sharma AC and Singh G (1997) Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am J Physiol 273, H827-H836.
11. Hess JR, MacDonald VW and Brinkley WW (1993) Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 74, 1769-1778.
12. Hyllner M, Tylman M, Bengtson JP, Rydberg L and Bengtsson A (2004) Complement activation in prestorage leucocytefiltered plasma. Transfus Med 14, 45-52.
13. Johnson JL, Moore EE, Offner PJ, Patrick DA, Tamura DY, Zallen G and Silliman CC (2004) Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma 50, 449-456.
14. Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, Condon MR, Lu Q, Xu DZ and Feinman R (2004) Persistent HIF-1alpha activation in gut ischemia/ reparfusion injury: potential role of bacteria and lipopolysaccharide. Shock 22, 270-277.
15. Luk CS, Gray-Statchuk LA, Capinkas G and Chin-Yee IH (2003) WBC reduction reduces storage-associated RBC adhesion to human vascular endothelial cells under conditions of continuous flow in vitro. Transfusion 43, 151-156.
16. Madjdpour C, Spahn DR and Weiskopf RB (2006) Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med 34 (5 Suppl), S102-108.
17. Masuno T, Moore EE, Cheng AM, Moore PK, Grant AR and Johnson JL (2005) Prehospital hemoglobin-based oxygen carrier resuscitation attenuates postinjury acute lung injury. Surgery 138, 335-341.
18. Moore EE, Cheng AM, Moore HB, Masuno T and Johnson JL (2006) Hemoglobin-based oxygen carriers in trauma care: scientific rationale for the US multicenter prehospital trial. World J Surg, [Epub ahead of print].
19. Moore EE, Johnson JL, Cheng AM, Masuno T and Banerjee A (2005) Insight from studies of blood substitutes in trauma. Shock 24, 197-205.
20. Moore FA, Moore EE and Sauaia A (1997) Blood transfusion: an independent risk factor for postinjury multiple organ failure. Arch Surg 132, 620-625.
21. Nielsen HJ, Reimert CM, Pedersen AM, Brunner N, Edvardsen L, Dybkjaer E, Kehlet H and Skov PS (1996) Time-dependent spontaneous release of white cell and platelet-derived bioactive substances from stored human blood. Transfusion 36, 960-965.
22. Poli de Figueiredo LF, Mathru M, Solanki D, Macdonald VW, Hess J and Kramer CC (1997) Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes. J Trauma 42, 847-856.
23. Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E and Intaglietta M (2000) Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279, H908-H915.
24. Sakai H, Horinouchi H, Masada Y, Takeoka S, Ikeda E, Takaori M, Kobayashi K and Tsuchida E (2004) Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomateria 25, 4317-4325.
25. Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, Kobayashi K and Tsuchida E (2004) Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 32, 539-545.
26. Sakamoto A, Matsumura J, Mii S, Gotoh Y and Ogawa R (2004) A prostaglandin E2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production. Shock 22, 76-81.
27. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ and Biffl WL (2004) Transfusion of the injured patient: proceed with caution. Shock 21, 291-299.
28. Terajima K, Tsueshita T, Sakamoto A and Ogawa R (2006) Fluid resuscitation with hemoglobin vesicles in a rabbit model of acute hemorrhagic shock. Shock 25, 184-189.
29. Watters JM, Brundage SI, Todd SR, Zautke NA, Stefater JA, Lam JC, Muller PJ, Malinoski D and Schreiber MA (2004) Resuscitation with lactated ringer's does not increase inflammatory response in a Swine model of uncontrolled hemorrhagic shock. Shock 22, 283-287.
30. Welsh DJ, Scott PH and Peacock AJ (2006) p38 MAP kinase isoform activity and cell cycle regulators in the proliferative response of pulmonary and systemic artery fibroblasts to acute hypoxia. Pulm Pharmacol Ther 19, 128-138.
31. Yoshizu A, Izumi Y, Park S, Sakai H, Takeoka S, Horinouchi H, Ikeda E, Tsuchida E and Kobayashi K (2004) Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-alpha. ASAIO J 50, 458-463.
32. Zallen G, Offner PJ, Moore EE, Blackwell J, Ciesla DJ, Gabriel J, Denny C and Silliman CC (1999) Age of transfused blood is an independent risk factor for post-injury multiple organ failure. Am J Surg 178, 570-572.